Post Mon Mar 20, 2023 3:14 pm

2023-Dai et al-Front Oncol

"Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden"
Mengyao Dai, Jianpeng Sheng, Qi Zhang, Jianxin Wang, Qihan Fu, Tingbo Liang
Front Oncol. 2023, 13, 1118633

- "Data availability statement The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation."